Forooghian F - Search Results

1

Alterations in intraocular cytokine levels following intravitreal ranibizumab.

Forooghian F, Kertes PJ, Eng KT, Albiani DA, Kirker AW, Merkur AB, Fallah N, Cao S, Cui J, Or C, Matsubara JA. Forooghian F, et al. Can J Ophthalmol. 2016 Apr;51(2):87-90. doi: 10.1016/j.jcjo.2015.11.001. Can J Ophthalmol. 2016. PMID: 27085264

2

Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.

Forooghian F, Kertes PJ, Eng KT, Agrón E, Chew EY. Forooghian F, et al. Invest Ophthalmol Vis Sci. 2010 May;51(5):2388-92. doi: 10.1167/iovs.09-4065. Epub 2009 Dec 10. Invest Ophthalmol Vis Sci. 2010. PMID: 20007836 Free PMC article.

3

Very minimal fluence photodynamic therapy for chronic central serous chorioretinopathy.

Butler AL, Fung AT, Merkur AB, Albiani DA, Forooghian F. Butler AL, et al. Among authors: forooghian f. Can J Ophthalmol. 2012 Feb;47(1):42-4. doi: 10.1016/j.jcjo.2011.12.020. Can J Ophthalmol. 2012. PMID: 22333850

4

Pro-inflammatory and anti-angiogenic effects of bisphosphonates on human cultured retinal pigment epithelial cells.

Or C, Cui J, Matsubara J, Forooghian F. Or C, et al. Among authors: forooghian f. Br J Ophthalmol. 2013 Aug;97(8):1074-8. doi: 10.1136/bjophthalmol-2013-303355. Epub 2013 Jun 13. Br J Ophthalmol. 2013. PMID: 23766431 Free PMC article.

5

Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.

Young M, Chui L, Fallah N, Or C, Merkur AB, Kirker AW, Albiani DA, Forooghian F. Young M, et al. Among authors: forooghian f. Retina. 2014 Jul;34(7):1308-15. doi: 10.1097/IAE.0000000000000081. Retina. 2014. PMID: 24451923

6

VOLUMETRIC ASSESSMENT OF THE RESPONSIVENESS OF PIGMENT EPITHELIAL DETACHMENTS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TO INTRAVITREAL BEVACIZUMAB.

Or C, Chui L, Fallah N, Forooghian F. Or C, et al. Among authors: forooghian f. Retina. 2016 Feb;36(2):264-71. doi: 10.1097/IAE.0000000000000795. Retina. 2016. PMID: 26418445

7

Long-term in vitro functional stability of compounded ranibizumab and aflibercept.

Cao S, Cui J, Matsubara J, Forooghian F. Cao S, et al. Among authors: forooghian f. Can J Ophthalmol. 2017 Jun;52(3):273-276. doi: 10.1016/j.jcjo.2016.11.012. Epub 2017 Jan 11. Can J Ophthalmol. 2017. PMID: 28576208

8

Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept.

Forooghian F, Albiani DA, Kirker AW, Merkur AB. Forooghian F, et al. Can J Ophthalmol. 2017 Dec;52(6):616-619. doi: 10.1016/j.jcjo.2017.04.016. Epub 2017 Jun 23. Can J Ophthalmol. 2017. PMID: 29217032

9

Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.

Hillier RJ, Ojaimi E, Wong DT, Mak MYK, Berger AR, Kohly RP, Kertes PJ, Forooghian F, Boyd SR, Eng K, Altomare F, Giavedoni LR, Nisenbaum R, Muni RH. Hillier RJ, et al. Among authors: forooghian f. JAMA Ophthalmol. 2018 Apr 1;136(4):382-388. doi: 10.1001/jamaophthalmol.2018.0179. JAMA Ophthalmol. 2018. PMID: 29522144 Free PMC article.

10

Probable autoimmune retinopathy in a patient with multiple sclerosis.

Forooghian F, Kertes PJ, Aptsiauri N. Forooghian F, et al. Can J Ophthalmol. 2003 Dec;38(7):593-7. doi: 10.1016/s0008-4182(03)80114-x. Can J Ophthalmol. 2003. PMID: 14740802 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters